Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?

European Journal of Endocrinology

Volumn 170, Issue 4, 2014, Pages 651-658

  Rogowicz Frontczak, Anita ^a   Zozulińska Ziółkiewicz, Dorota ^a   Litwinowicz, Monika ^a   Niedźwiecki, Paweł ^a   Wyka, Krystyna ^b   Wierusz Wysocka, Bogna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN ANTIBODY; TYROSINE PHOSPHATASE ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER TYPE 8 ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DIABETES MELLITUS; AUTOIMMUNE THYROIDITIS; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IODIDE PEROXIDASE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; RISK FACTORS; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 84899488931     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0901     Document Type: Article

References (32)

1. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553. (doi:10.1002/(SICI) 1096-9136 (199807) 15:7<539::AID- DIA668>3.0. CO;2-S)
2. Naik RG & Palmer JP. Latent autoimmune diabetes in adults (LADA). Reviews in Endocrine & Metabolic Disorders 2003 4233-241. (doi:10.1023/A:1025148211587)
3. Zimmet PZ. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care 1995 18 1050-1064.
4. Pozzilli P & Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 2001 24 1460-1467. (doi:10.2337/diacare.24.8.1460)
5. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999 48 150-157. (doi:10.2337/diabetes.48.1.150)
6. Maruyama T, Shimada A, Kanatsuka A, Kasuga A, Takei I, Yokoyama J & Kobayashi T. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Annals of the New York Academy of Sciences 2003 1005 362-369. (doi:10.1196/annals.1288.060)
7. Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Marechaud R et al. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid β-cell loss in patients with tight metabolic control. Diabetes & Metabolism 2010 36 64-70. (doi:10.1016/j.diabet.2009.07.004)
8. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG & Harrison LC. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005 48 2206-2212. (doi:10.1007/s00125-005-1960-7)
9. Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, Di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care 2010 33 104-108. (doi:10.2337/dc08-2305)
10. Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ & Palmer JP. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1 (1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 2001 50 1008-1013. (doi:10.1053/meta.2001.25654)
11. Borg H, Gottsater A, Fernlund P & Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002 51 1754-1762. (doi:10.2337/diabetes.51.6.1754)
12. Chimienti F, Favier A & Seve M. ZnT-8, a pancreatic β-cell-specific zinc transporter. Biometals 2005 18 313-317. (doi:10.1007/s10534-005-3687-9)
13. Andersson C, Vaziri-Sani F, Delli A, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson S et al. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatric Diabetes 2013 14 97-105. (doi:10.1111/j.1399-5448.2012. 00916.x)
14. Rosario PW, Reis JS, Borges MA, Amim R, Calsolari MR, Silva SC & Purisch S. Extrapancreatic autoimmunity in patients with latent autoimmune diabetes of adults. Diabetes Care 2005 28 496-497. (doi:10.2337/diacare.28.2. 496-a)
15. Zampetti S, Capizzi M, Spoletini M, Campagna G, Leto G, Cipolloni L, Tiberti C, Bosi E, Falorni A & Buzzetti R. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). Journal of Clinical Endocrinology and Metabolism 2012 97 3759-3765. (doi:10.1210/jc.2012-2037)
16. Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orru V, Secchi G, Cicalo AM et al. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. European Journal of Endocrinology 2010 163 541-549. (doi:10.1530/EJE-10-0427)
17. Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W & Zhou Z. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Clinical Endocrinology 2011 74 587-592. (doi:10.1111/j.1365-2265.2011.03976.x)
18. Rogowicz-Frontczak A, Zozulinska-Ziolkiewicz D, Niedzwiecki P, Litwinowicz M & Wierusz-Wysocka B. Does glucagon stimulation test help to predict autoimmunity in newly diagnosed non obese adults with diabetes? Experimental and Clinical Endocrinology & Diabetes 2012 120 428-434. (doi:10.1055/s-0032-1308979)
19. Davis TM, Wright AD, Mehta ZM, Cull CA, Stratton IM, Bottazzo GF, Bosi E, Mackay IR & Holman RR. Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 2005 48 695-702. (doi:10.1007/s00125-005-1690-x)
20. Bottazzo GF, Bosi E, Cull CA, Bonifacio E, Locatelli M, Zimmet P, Mackay IR & Holman RR. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 2005 48 703-708. (doi:10.1007/s00125-005-1691-9)
21. Trabucchi A, Faccinetti NI, Guerra LL, Puchulu FM, Frechtel GD, Poskus E & Valdez SN. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity 2012 45 137-142. (doi:10.3109/08916934.2011.604658)
22. Chang CC, Huang CN & Chuang LM. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. European Journal of Endocrinology 1998 139 44-48. (doi:10.1530/eje.0.1390044)
23. Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M et al. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 2005 28 850-855. (doi:10.2337/diacare.28.4.850)
24. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M & Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002 25 1346-1350. (doi:10.2337/diacare.25. 8.1346)
25. Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, Crockett S, She JX & Maclaren NK. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in β-cell autoimmunity. Journal of Clinical Endocrinology and Metabolism 1996 81 2559-2563.
26. Kucera P, Novakova D, Behanova M, Novak J, Tlaskalova-Hogenova H & Andel M. Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA). Clinical and Experimental Immunology 2003 133 139-143. (doi:10.1046/j.1365-2249. 2003.02205.x)
27. Kawasaki E, Yasui J, Tsurumaru M, Takashima H, Ikeoka T, Mori F, Akazawa S, Ueki I, Kobayashi M, Kuwahara H et al. Sequential elevation of autoantibodies to thyroglobulin and glutamic acid decarboxylase in type 1 diabetes. World Journal of Diabetes 2013 4 227-230.
28. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S & Nagataki S. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994 43 80-86. (doi:10.2337/diab.43.1.80)
29. Jonsdottir B, Andersson C, Carlsson A, Delli A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ortqvist E, Lernmark A et al. Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents. Diabetologia 2013 56 1735-1742. (doi:10.1007/s00125-013-2934-9)
30. Kawasaki E. ZnT8 and type 1 diabetes. Endocrine Journal 2012 59 531-537. (doi:10.1507/endocrj. EJ12-0069)
31. Murgia C, Devirgiliis C, Mancini E, Donadel G, Zalewski P & Perozzi G. Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands. Nutrition, Metabolism, and Cardiovascular Diseases 2009 19 431-439. (doi:10.1016/j.numecd.2008.09.004)
32. Gale EA. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 2005 48 2195-2199. (doi:10.1007/s00125-005-1954-5)